Condition

Acute Myeloid Leukaemia clinical trials and research

• 7Clinical trials
• 12Countries

Newest Acute Myeloid Leukaemia clinical trials

All recruiting trials (7)

• AMX-883 in AML and high-risk MDS: a first-in-class dosing study

  This early-stage study tests AMX-883 alone and with another drug to see if it is safe and shows early signs of benefit in people with AML or high-risk MDS.

  Recruiting at 3 sites Phase 1 Amphista Therapeutics Ltd · New York, New York and 2 other locations · NCT07723703

• AZD3632, alone or with other anticancer agents, for advanced blood cancers driven by HOX overexpression

  This trial will test whether the oral drug AZD3632, given alone or with the antifungal posaconazole, is safe and helps control relapsed or refractory AML, ALL, or high-risk MDS that have KMT2A rearrangements, NPM1 mutations, or other genotypes causing HOX overexpression.

  Recruiting at 20 sites Phase 1/2 AstraZeneca · Decatur, Illinois and 29 other locations · NCT07155226

• U32 CAR-T for acute myeloid leukemia

  This will test whether U32 CAR-T is safe and can help people aged 2–65 with relapsed or refractory acute myeloid leukemia.

  Recruiting Phase 1/2 Shanghai Unicar-Therapy Bio-medicine Technology Co.,Ltd · Suzhou · NCT07036250

• Evaluating treatment protocols for pediatric acute myeloid leukemia in Malawi

  This study is testing a new treatment plan for children with acute myeloid leukemia in Malawi to see if it can help them survive better and handle side effects more easily.

  Recruiting Baylor College of Medicine · Lilongwe, Lilongwe · NCT06928909

• Monalizumab treatment for patients with blood cancers undergoing stem cell transplantation

  This study is testing if a new treatment called Monalizumab can help people with blood cancers like AML or MDS who are getting stem cell transplants by improving their immune response and reducing the chances of disease returning or complications.

  Recruiting at 2 sites Phase 2 Istituto Clinico Humanitas · Genova, GENOVA and 1 other locations · NCT06892223

• HPV vaccination after allogeneic stem cell transplant

  This trial will test whether giving the 9‑valent HPV vaccine early or later after an allogeneic stem cell transplant produces a protective antibody response in adults up to age 45 who had a transplant.

  Recruiting at 3 sites Phase 2 Vastra Gotaland Region · Lund, Region Skåne and 4 other locations · NCT06793410

• New treatment approach for newly diagnosed Acute Myeloid Leukemia

  This study is testing a new combination treatment for people with newly diagnosed Acute Myeloid Leukemia to see if it works better than the usual chemotherapy.

  Recruiting Phase 3 Zhongnan Hospital · Zhengzhou, Henan and 10 other locations · NCT06345365

Related topics

Quick answers

How many Acute Myeloid Leukaemia clinical trials are recruiting right now?

7, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.

Where are these trials running?

In 12 countries. The most sites are in China (2 trials), United Kingdom (2 trials), United States (2 trials), Italy (2 trials), Malawi (1 trial). Each study page lists its sites and which ones are recruiting.

What phases are they in?

Phase 1/2: 2, Phase 2: 2, Phase 1: 1, Phase 3: 1. Trials with no phase listed are usually device, behavioural or observational studies.

How do I join one?

Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.

Find the studies that fit you

A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.

Describe your situation →